These Stocks Are Steamrolling Everything in their Path...

Crushing the competition... February 19, 2015 Archives | Unsubscribe     These Stocks Are Steamrolling Everything in their Path...   Crushing the competition The one sector poised for huge gains Plus: Revenge of the franken-milk   Greg Guenthner coming to you from Baltimore, MD... Hey, I see you sitting there at your computer like a wimp, with your pumpkin spice latte and lilac crème crepe. Put 'em away. It's time to get to work... Today you're hopping on a good ole fashioned steamroller for an honest day's pay. Your job is to turn every underperforming industry and market sector into pancakes... So grab your lunch pail, put on a hard hat and get ready to roll, my man. It's time to flatten financials...utilities...and industrial stocks. They're dragging down the S&P 500 - and maybe your portfolio, too. What's left will be a few indestructible diamonds screaming "buy me!" These are the powerhouse stocks that'll supercharge your trading account over the next few months. And my favorite these days? Biotech stocks. Yeah, yeah, yeah--we've been on a heavy biotech diet lately. But with good reason. While every trader this side of Timbuktu got waylaid by the oil crash, guess which sector was as solid as granite? Biotechs, that's what. Back in late October, just a little less than two weeks removed from the start of the epic fall comeback, I told you I was backing up the truck on biotech. A massive biotech breakout had arrived, with promises of wild profits. So far, it's delivered. And listen, they still have plenty of room to run... The main clue here is the strength it showed while the major averages consolidated. After the market bottomed out back in October, the S&P 500 recovered, but was as flat as a board until just recently. But biotech stocks kept packing on the muscle... Over the past six months, the S&P is up a skinny 6%, while the Biotech iShares (NASDAQ:IBB) have bulked up 23%. So I gotta ask you: Where would you rather put your money right now? The S&P... or biotechs? Unless you've got a room-temperature IQ, the answer's obvious. And listen, here's the best part about this trade... You don't have to be that choosy when it comes to playing biotech right now. IBB is the big, safe sector giant. But there are individual biotech stocks with the potential to return eye-popping gains in just a few days or weeks--as long as you're not caught in an earnings snafu. The rest is up to you...         Why Is the Government Preparing for Catastrophe?   Our government has begun emergency preparations for a disastrous event that could take place as early as March.   What do authorities know that we don't? And why aren't they alerting everyday Americans like you and me?   Click here and see all the details for yourself.           Rude Numbers Targets, Predictions and Wild Guesses   $50.66 buys a barrel of oil this morning. Crude is reeling as inventories rise sharply. It's down 4% so far today... $1,220 is where you'll find gold futures this morning. After dropping below $1,199 yesterday, gold is springing back to life thanks in part to yesterday's FOMC minutes... $16.75 marks the spot for silver futures. The poor man's precious metal is also enjoying a rally this morning. It's up nearly 3%... $2.87 is the price of natural gas today. Natty looks like its finally trying to bottom out after dropping for nearly 3 months straight... 2,092 marks the spot for S&P futures before the morning bell. Stocks are looking to open just below yesterday's close...     Rude Trends When to Buy... When to Sell   Well, I finally did it... I located and purchased Fairlife, the Coca-Cola owned milk product. The grocery store that carried it only had about five or six jugs crammed in the cooler near the half and half. I don't know if that means it was close to sold out or if they're limiting distribution until the stuff catches on. Either way, I paid about $4.50 for the thing. I opted for the 2% version, picked up some other stuff on my list, headed home, and immediately poured a small glass. I gotta tell ya--the stuff tastes great. I'm not really sure how to describe it. Fairlife tastes like cream, but has the consistency of milk. It's good. I wasn't expecting that... Will this super milk give me super-mutant powers? I'm not sure yet. I'll finish the jug and keep you in the loop. But if you're a milk person, you might want to try it. I don't know if it will ever really catch on, but it's worth at least a test run... [Ed. Note: Send your feedback here: rude@agorafinancial.com - and follow me on Twitter: @GregGuenthner]     Ignore At Your Own Peril Today's Must Read Links   How to "Disappear" from the IRS... World's Most Valuable Tech Companies for 21-Cents? You Won't Believe How Obama Made $9.2 Billion [must see]     BE SURE TO ADD rude@agorafinancial.com to your address book.       Additional Articles & Commentary: Join the conversation! Follow us on social media:         The Rude Awakening is committed to protecting and respecting your privacy. We do not rent or share your email address. By submitting your email address, you consent to Agora Financial delivering daily email issues and advertisements. To end your Rude Awakening e-mail subscription and associated external offers sent from The Rude Awakening, click here. Please read our Privacy Statement. For any further comments or concerns please email us at rude@agorafinancial.com. If you are you having trouble receiving your Rude Awakening subscription, you can ensure its arrival in your mailbox by whitelisting The Rude Awakening. © 2015 Agora Financial, LLC. 808 Saint Paul Street, Baltimore MD 21202. Although our employees may answer your general customer service questions, they are not licensed under securities laws to address your particular investment situation. No communication by our employees to you should be deemed as personalized investment advice. We expressly forbid our writers from having a financial interest in any security they personally recommend to our readers. All of our employees and agents must wait 24 hours after on-line publication or 72 hours after the mailing of a printed-only publication prior to following an initial recommendation. Any investments recommended in this letter should be made only after consulting with your investment advisor and only after reviewing the prospectus or financial statements of the company.